Early evidence suggests GLP-1s were linked to lower risks of developing substance use disorders — from alcohol to opioids — and to fewer overdoses and deaths in people with existing addictions.

Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, drinking and opioid use disorders and addiction.

A new study, led by researchers at the independent scientific research institute RTI International and the Bureau of Economic Analysis, found that national spending on treatment for mental health and ...

Between four and 10 million people in the U.S. have fibromyalgia. Many doctors look askance at the disorder, leading some ...

Cannabis compounds may reduce symptoms for some disorders, but evidence quality is low ...

A massive study of 700,000 medical records reveals that teenagers with cannabis use disorder face a 52% higher risk of schizophrenia compared to those using other substances.

Substance use disorder makes it hard to stop using substances even when they're harmful. Using the term "substance use disorder" helps separate the person from the treatable illness. Substance use ...

Substance use and substance use disorder differ by the frequency of use and the effect on a person’s life. Substance use disorder is a mental health condition. Substance use refers to using both legal ...

Researchers at Washington University School of Medicine in St. Louis have shown in a new study that GLP-1 medications may be ...

Ryan Paige has called Biddeford home his entire life. He grew up in the city, attended its schools and spent time with ...